Guaifenesin Dosing for a 6-Year-Old, 22 kg Child
For a 6-year-old male weighing 22 kg, the appropriate guaifenesin dose is 100-200 mg every 4 hours (not to exceed 1200 mg/24 hours), which translates to 5-10 mL of standard oral solution (100 mg/5 mL) every 4 hours.
Dosing Rationale
The FDA-approved guaifenesin oral solution is available as 100 mg/5 mL 1. For this 22 kg child:
- Standard pediatric dosing: Children ages 6-11 years typically receive 100-200 mg every 4 hours
- Weight-based consideration: At 22 kg, this child falls within the typical weight range for age-appropriate dosing
- Volume administration: This equals 5-10 mL per dose of the standard solution every 4 hours
Practical Administration
Dose flexibility: The dosing range allows titration based on symptom severity. Start with 5 mL (100 mg) and increase to 10 mL (200 mg) if needed for adequate mucus clearance 2.
Maximum daily dose: Do not exceed 6 doses in 24 hours (maximum 1200 mg/day for this age group).
Rounding considerations: Guaifenesin allows for 15% dose rounding 3, meaning minor adjustments for ease of administration are acceptable given its wide therapeutic window and low risk of dose-dependent adverse effects.
Clinical Context
Guaifenesin acts as an expectorant by loosening mucus in airways and making coughs more productive 4. While evidence for efficacy in acute upper respiratory infections shows mixed results 5, it remains the only FDA-approved OTC expectorant and has demonstrated benefit in conditions with mucus hypersecretion 4, 6.
Safety profile: Guaifenesin has a well-established favorable safety profile in pediatric populations with minimal adverse effects 4. The wide therapeutic index makes dose variations relatively safe.
Formulation note: Sugar-free and alcohol-free formulations are available 1, which may be preferable for pediatric use.
Important Caveats
- Multiple daily doses are required with immediate-release formulations to maintain therapeutic effect throughout the day 4
- Clinical response varies; if no improvement after 7 days, reassess the diagnosis
- Ensure adequate hydration to optimize mucolytic effects
- Extended-release formulations exist for adults but are not typically used in this age group